Beyond Air Inc (NASDAQ:XAIR) — Market Cap & Net Worth
Market Cap & Net Worth: Beyond Air Inc (XAIR)
Beyond Air Inc (NASDAQ:XAIR) has a market capitalization of $2.22 Million ($2.22 Million) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #29992 globally and #6103 in its home market, demonstrating a -8.88% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Beyond Air Inc's stock price $3.08 by its total outstanding shares 720531 (720.53K). Also see balance sheet size of Beyond Air Inc for a full breakdown of the balance sheet.
Beyond Air Inc Market Cap History: 2016 to 2026
Beyond Air Inc's market capitalization history from 2016 to 2026. Data shows growth from $216.16K to $2.22 Million (24.33% CAGR). Also see Beyond Air Inc (XAIR) cash flow conversion for how efficiently the company converts equity into cash flow.
Index Memberships
Beyond Air Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.66 Trillion | 0.00% | #876 of 976 |
|
NASDAQ Composite
IXIC
|
$41.69 Trillion | 0.00% | #2795 of 3165 |
Weight: Beyond Air Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Beyond Air Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Beyond Air Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Beyond Air Inc stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.29x
Beyond Air Inc's market cap is 0.29 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $3.77 Million | $7.72 Million | -$6.56 Million | 0.49x | N/A |
| 2020 | $3.80 Million | $1.39 Million | -$19.94 Million | 2.73x | N/A |
| 2021 | $6.80 Million | $873.00K | -$22.88 Million | 7.79x | N/A |
| 2022 | $4.68 Million | $145.19K | -$43.18 Million | 32.21x | N/A |
| 2023 | $1.41 Million | $59.00K | -$55.82 Million | 23.94x | N/A |
| 2024 | $258.31K | $1.16 Million | -$60.24 Million | 0.22x | N/A |
| 2025 | $523.11K | $3.71 Million | -$46.62 Million | 0.14x | N/A |
| 2026 | $2.22 Million | $7.68 Million | -$33.25 Million | 0.29x | N/A |
Competitor Companies of XAIR by Market Capitalization
Companies near Beyond Air Inc in the global market cap rankings as of September 18, 2026. Review XAIR tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Beyond Air Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #125 globally with a market cap of $177.99 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #229 globally with a market cap of $109.23 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #125 | Abbott Laboratories | NYSE:ABT | $177.99 Billion | $102.36 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.60 |
| #229 | Stryker Corporation | NYSE:SYK | $109.23 Billion | $284.76 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Beyond Air Inc Historical Marketcap From 2016 to 2026
Between 2016 and today, Beyond Air Inc's market cap moved from $216.16K to $ 2.22 Million, with a yearly change of 24.33%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $2.22 Million | +324.24% |
| 2025 | $523.11K | +102.51% |
| 2024 | $258.31K | -81.71% |
| 2023 | $1.41 Million | -69.80% |
| 2022 | $4.68 Million | -31.25% |
| 2021 | $6.80 Million | +79.13% |
| 2020 | $3.80 Million | +0.76% |
| 2019 | $3.77 Million | +12.47% |
| 2018 | $3.35 Million | -6.81% |
| 2017 | $3.60 Million | +1563.33% |
| 2016 | $216.16K | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of Beyond Air Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.22 Million USD |
| MoneyControl | $2.22 Million USD |
| MarketWatch | $2.22 Million USD |
| marketcap.company | $2.22 Million USD |
| Reuters | $2.22 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Beyond Air Inc
Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company. It operates through Beyond Air, Beyond Cancer, and NeuroNos segments. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO to treat viral lung infections, such as viral community-acquired pneumonia, including COVID-19 and b… Read more